C1S-Targeted Inhibition Of Classical Complement Pathway By Sutimlimab In Cold Agglutinin Disease (Cad): Efficacy And Safety Results From The Randomized, Placebo (Pbo)-Controlled Phase 3 Cadenza Study
Sutimlimab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: C1S-Targeted Inhibition Of Classical Complement Pathway By Sutimlimab In Cold Agglutinin Disease (Cad): Efficacy And Safety Results From The Randomized, Placebo (Pbo)-Controlled Phase 3 Cadenza Study ### Output: Sutimlimab